Mutations of MMR genes have been associated with mutations of the KRAS or EGFR genes in NSCLC patients; however, this association has not translated into a prognostic or predictive implication on the response to chemotherapy or immunotherapy [11]. Here, MRC1 is linked to non-small cell lung carcinoma.